Cocaine dependence, fissure.
Conditions
Interventions
After inclusion, the fifty patients will be randomly assigned to either Homeopathy other Placebo groups and treated as follows:
Homeopathy:
- treatment as usual from CRATOD and
- Opium Q2 or 2LM - 1
drug
Sponsors
Universidade Federal de São Paulo
Centro de Referência de Álcool, Tabaco e Outras Drogas da Secretaria de Estado da Saúde
Eligibility
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients between 18 and 65 years, who met DSM-IV TR criteria for cocaine dependence Capacity and willingness to give informed consent and to comply with study procedures were also required.
Exclusion criteria
Exclusion criteria: Disabling clinical or psychiatric diseases that would hinder regular participation in the study; acupunture or homeopathic treatment simultaneously to the study; simultaneous participation in another clinical trial; concomitant pregnancy; patients who are assumed to have a linguistic, intellectual or any other reason for not understanding the meaning of the clinical trial and for not complying with the necessary study procedures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary efficacy measure is the mean craving score, measured by the first item of the Minnesota Cocaine Craving Scale at week 4. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end points include the same craving score at weeks 1, 2 and 3 and the remaining craving measures of the Minnesota Cocaine Craving Scale (frequency, duration of craving, changes in relation to previous week and craving response to medication). Tolerability is assessed with the side effect rating scale of the Scandinavian Society of Psychopharmacology. | — |
Countries
Brazil
Contacts
Public ContactUBIRATAN ADLER
UNIFESP
Outcome results
None listed